Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies,2022 Update

Description

List of Tables

GlobalData's Medical Devices sector report, "Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Aesthetic injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Aesthetic Injectables under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Aesthetic Injectables under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product's current stage of development, territory and estimated launch date

Product Code: GDME1354EPD

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Aesthetic Injectables Overview

3 Products under Development

3.1 Aesthetic Injectables - Pipeline Products by Stage of Development
3.2 Aesthetic Injectables - Pipeline Products by Segment
3.3 Aesthetic Injectables - Pipeline Products by Territory
3.4 Aesthetic Injectables - Pipeline Products by Regulatory Path
3.5 Aesthetic Injectables - Pipeline Products by Estimated Approval Date
3.6 Aesthetic Injectables - Ongoing Clinical Trials

4 Aesthetic Injectables - Pipeline Products under Development by Companies

4.1 Aesthetic Injectables Companies - Pipeline Products by Stage of Development
4.2 Aesthetic Injectables - Pipeline Products by Stage of Development

5 Aesthetic Injectables Companies and Product Overview

5.1 Acro Biomedical Co Ltd Company Overview
5.2 Advanced Aesthetic Technologies Inc Company Overview
5.3 Aeon Astron Corporation Company Overview
5.4 Aesthetic Medical Device Company Overview
5.5 Allergan Aesthetics Company Overview
5.6 Almirall Ltd Company Overview
5.7 BioPlus Co Ltd Company Overview
5.8 Bioxis Pharmaceuticals Company Overview
5.9 BMG Pharma SpA Company Overview
5.10 Bmi Korea Co Ltd Company Overview
5.11 CellPraxis Company Overview
5.12 Celltrix AB Company Overview
5.13 Collplant Biotechnologies Ltd Company Overview
5.14 Dexlevo Inc Company Overview
5.15 EternoGen Aesthetics LLC Company Overview
5.16 Fillmed Laboratoires Company Overview
5.17 Genzyme Corp Company Overview
5.18 Hallura Ltd Company Overview
5.19 Histogen Inc Company Overview
5.20 Hugel Inc Company Overview
5.21 Innovia LLC Company Overview
5.22 Juvenis Ltd Company Overview
5.23 Khorionyx SA Company Overview
5.24 LG Chem Ltd Company Overview
5.25 LifeSprout Inc Company Overview
5.26 Medytox Inc Company Overview
5.27 Merz North America Inc Company Overview
5.28 Mesoestetic Pharma Group SL Company Overview
5.29 Moma Therapeutics Inc Company Overview
5.30 N8 Medical LLC Company Overview
5.31 Oligo Medic Inc Company Overview
5.32 PB&B SA Company Overview
5.33 PetVivo Holdings Inc Company Overview
5.34 Q-Med AB Company Overview
5.35 Revance Therapeutics Inc Company Overview
5.36 Samyang Biopharmaceuticals Corp Company Overview
5.37 Sebana Medical Ltd Company Overview
5.38 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.39 Shin Poong Pharm Co Ltd Company Overview
5.40 Silk Medical Aesthetics Inc Company Overview
5.41 Sinclair Pharma Ltd Company Overview
5.42 Sofregen Medical Inc Company Overview
5.43 SunMax Biotechnology Co Ltd Company Overview
5.44 TEI Biosciences Inc Company Overview
5.45 Tempo Therapeutics Inc Company Overview
5.46 Teoxane SA Company Overview
5.47 Tissueform Inc Company Overview
5.48 University of California Santa Barbara Company Overview

6 Aesthetic Injectables- Recent Developments

6.1 Nov 17, 2021: Silk Medical Aesthetics announces feasibility clinical trial results for its all-natural dermal filler

7 Appendix

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

Product Code: GDME1354EPD

List of Tables

Aesthetic Injectables - Pipeline Products by Stage of Development
Aesthetic Injectables - Pipeline Products by Segment
Aesthetic Injectables - Pipeline Products by Territory
Aesthetic Injectables - Pipeline Products by Regulatory Path
Aesthetic Injectables - Pipeline Products by Estimated Approval Date
Aesthetic Injectables - Ongoing Clinical Trials
Aesthetic Injectables Companies - Pipeline Products by Stage of Development
Aesthetic Injectables - Pipeline Products by Stage of Development
Glossary

List of Figures

Aesthetic Injectables - Pipeline Products by Stage of Development
Aesthetic Injectables - Pipeline Products by Segment
Aesthetic Injectables - Pipeline Products by Territory
Aesthetic Injectables - Pipeline Products by Regulatory Path
Aesthetic Injectables - Pipeline Products by Estimated Approval Date
Aesthetic Injectables - Ongoing Clinical Trials